Last year was a surprisingly big one for legal decisions impacting the biotechnology transactions and licensing space. Given that most biotech deals are subject to confidential alternative dispute resolution, it is unusual...more
1/27/2025
/ Bayh-Dole Act ,
Biotechnology ,
Contract Terms ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
IP License ,
Licenses ,
Licensing Rules ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Regulatory Requirements